Carmustine: Properties, Handling & Research Use FAQs

Carmustine is a bifunctional alkylating nitrosourea compound widely used in cancer biology research and as a reference standard for studies targeting DNA crosslinking and repair mechanisms.

Chemical Name

1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)

CAS Number

154-93-8

Molecular Formula

C5H9Cl2N3O2

Molecular Weight

214.05 g/mol

Mechanism of Action

Bifunctional alkylation and carbamoylation of DNA, leading to interstrand crosslinks and inhibition of DNA repair

Solubility

Soluble in ethanol and DMSO; poorly soluble in water

Storage

Store at -20 °C, protected from light and moisture

What Is Carmustine and How Does It Work?

Carmustine (BCNU; 1,3-bis(2-chloroethyl)-1-nitrosourea; CAS 154-93-8) is a lipophilic bifunctional alkylating agent belonging to the nitrosourea class. Its mechanism of action involves two distinct chemical reactions: alkylation of DNA bases—particularly at the O6 and N7 positions of guanine—resulting in intrastrand and interstrand DNA crosslinks, and carbamoylation of lysine residues in proteins, which inhibits key DNA-repair enzymes. Because of its high lipophilicity, carmustine crosses the blood–brain barrier efficiently, making it a frequently studied compound in glioma and CNS tumor models. In the research laboratory, it is used as a tool compound to induce controlled DNA damage and to study cellular DNA-damage response pathways.

Solubility, Formulation and Stock Solution Preparation

Carmustine is sparingly soluble in water but dissolves readily in anhydrous ethanol and in DMSO. For most in vitro assays, a 10–50 mM stock solution in DMSO or absolute ethanol is recommended; the stock should be prepared fresh or aliquoted and stored at -20 °C to minimize hydrolytic degradation. When diluting into aqueous culture media, ensure the final organic-solvent concentration does not exceed 0.1–0.5% (v/v) to avoid cytotoxic solvent artefacts. Do not prepare aqueous solutions in advance, as carmustine undergoes rapid hydrolysis at physiological pH and temperature. Always use glass or polypropylene vessels; carmustine can interact with certain plastics.

Tip: Sonication in a water bath (room temperature, ≤5 min) can assist dissolution without exposing the compound to excessive heat.

Storage, Stability and Handling Precautions

Store carmustine as a solid at -20 °C in a tightly sealed container, protected from light and moisture. Under these conditions the compound is stable for the duration of the shelf life stated on the certificate of analysis. Avoid repeated freeze–thaw cycles of stock solutions. Carmustine is a potent alkylating agent and a known carcinogen, mutagen and reproductive toxicant; it must be handled in accordance with institutional chemical safety protocols. Always work in a certified chemical fume hood or biological safety cabinet, wearing appropriate PPE: nitrile gloves, lab coat and safety glasses as a minimum. Refer to the Safety Data Sheet (SDS) before use. Waste must be disposed of as hazardous chemical waste in compliance with local regulations.

Research Applications of Carmustine

In preclinical research, carmustine is employed in several contexts:

• In vitro cytotoxicity models: Dose–response studies in glioblastoma (e.g., U87, T98G), lymphoma and other cancer cell lines to characterize chemosensitivity and resistance mechanisms.
• DNA damage and repair studies: Induction of defined interstrand crosslinks (ICLs) to interrogate homologous recombination, nucleotide excision repair and the Fanconi anaemia pathway.
• Drug combination screening: BCNU is used as a reference alkylator when evaluating synergy with MGMT inhibitors (e.g., O6-benzylguanine), temozolomide or PARP inhibitors.
• In vivo xenograft models: Subcutaneous and intracranial rodent models of glioma to evaluate efficacy and pharmacokinetics.
• Wafer/local delivery research: Investigation of controlled-release polymer systems inspired by the clinical polifeprosan 20 with carmustine implant (Gliadel®) as a benchmark.

Quality, Purity and Documentation

Aladdin Scientific's Carmustine (SKU C132260) is supplied with a certificate of analysis (CoA) confirming identity and purity. Purity is typically assessed by HPLC and/or NMR. Researchers requiring specific purity thresholds (e.g., ≥98% for pharmacological assays) should confirm the lot-specific CoA prior to ordering. A Safety Data Sheet (SDS) compliant with GHS/OSHA HazCom standards is available for download from the product page. For custom quantities, higher-purity grades or bulk pricing, contact Aladdin Scientific technical sales.

Frequently asked questions

What solvent should I use to dissolve Carmustine for cell culture experiments?

Carmustine dissolves well in DMSO or absolute ethanol; a 10–50 mM stock in either solvent is appropriate for most assays. Dilute into pre-warmed culture medium immediately before use and keep the final solvent concentration below 0.1–0.5% (v/v). Avoid preparing aqueous stock solutions in advance because carmustine hydrolyzes rapidly at physiological pH.

How should Carmustine be stored to ensure stability?

Store the solid compound at -20 °C in a tightly sealed, light-protected container away from moisture. DMSO or ethanol stock solutions should be aliquoted to avoid repeated freeze–thaw cycles and stored at -20 °C. Always verify the expiry date on the certificate of analysis before use.

What safety precautions are required when handling Carmustine in the laboratory?

Carmustine is classified as a carcinogen, mutagen and reproductive toxicant. All handling must be performed in a certified chemical fume hood or biological safety cabinet with appropriate PPE including nitrile gloves, lab coat and safety glasses. Consult the SDS for full hazard information, and dispose of all waste as hazardous chemical waste according to institutional and local regulatory requirements.

Why is Carmustine used in brain tumor research specifically?

Carmustine's high lipophilicity enables it to cross the blood–brain barrier efficiently, a property that most conventional hydrophilic chemotherapeutics lack. This makes it especially relevant for preclinical models of glioblastoma and other CNS malignancies, where drug penetration into the brain parenchyma is a critical pharmacological challenge.

Can Carmustine be used in combination with MGMT inhibitors in research assays?

Yes. Carmustine is frequently combined with O6-methylguanine-DNA methyltransferase (MGMT) inhibitors such as O6-benzylguanine in research settings to study how MGMT-mediated DNA repair contributes to nitrosourea resistance. Such combination experiments help elucidate resistance mechanisms and guide the rational design of chemosensitization strategies.

References

1. Colvin M. The alkylating agents. In: Chabner BA, Longo DL, eds. Cancer Chemotherapy and Biotherapy: Principles and Practice. Lippincott Williams & Wilkins; 2006.
2. Friedman HS, Kerby T, Calvert H. Temozolomide and treatment of malignant glioma. Clin Cancer Res. 2000;6(7):2585-2597. PMID:10914716
3. Denny BJ, et al. NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug carmustine. Biochemistry. 1994;33(31):9286-9294. PMID:8049232
4. Westphal M, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol. 2003;5(2):79-88. doi:10.1215/S1522-8517-02-00023-6

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.